Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McDermott

Showing results (401-410 of 567) with videos related to

Pageof 57
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 7, 2021
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trialMichael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Clinical Genitourinary Cancer|April 3, 2016
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell CarcinomaKathleen M Mahoney, Susanna Jacobus, Rupal S Bhatt, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinomaBrian I Rini, Sabina Signoretti, Toni K Choueiri, et al.
The Journal of Antimicrobial Chemotherapy|July 5, 2015
WGS accurately predicts antimicrobial resistance in Escherichia coliGregory H Tyson, Patrick F McDermott, Cong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2020
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint InhibitorsAnita Gul, Tyler F Stewart, Charlene M Mantia, et al.
Genes and Immunity|November 5, 2004
TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre studyA C Gordon, A L Lagan, E Aganna, et al.
JAMA|December 5, 1997
Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trialR R Roberts, R J Zalenski, E K Mensah, et al.
The Oncologist|September 8, 2018
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell CarcinomaToni K Choueiri, M Dror Michaelson, Edwin M Posadas, et al.
Foodborne Pathogens and Disease|May 7, 2010
Multidrug-resistant Salmonella isolates from retail chicken meat compared with human clinical isolatesNkuchia M M'ikanatha, Carol H Sandt, A Russell Localio, et al.
Cancer|March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitorsAllison Ackerman, Oliver Klein, David F McDermott, et al.
Pageof 57

Showing results (401-410 of 567) with videos related to

Sort By:
Pageof 57
European Journal of Cancer (Oxford, England : 1990)|January 7, 2021
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trialMichael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Clinical Genitourinary Cancer|April 3, 2016
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell CarcinomaKathleen M Mahoney, Susanna Jacobus, Rupal S Bhatt, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinomaBrian I Rini, Sabina Signoretti, Toni K Choueiri, et al.
The Journal of Antimicrobial Chemotherapy|July 5, 2015
WGS accurately predicts antimicrobial resistance in Escherichia coliGregory H Tyson, Patrick F McDermott, Cong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2020
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint InhibitorsAnita Gul, Tyler F Stewart, Charlene M Mantia, et al.
Genes and Immunity|November 5, 2004
TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre studyA C Gordon, A L Lagan, E Aganna, et al.
JAMA|December 5, 1997
Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trialR R Roberts, R J Zalenski, E K Mensah, et al.
The Oncologist|September 8, 2018
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell CarcinomaToni K Choueiri, M Dror Michaelson, Edwin M Posadas, et al.
Foodborne Pathogens and Disease|May 7, 2010
Multidrug-resistant Salmonella isolates from retail chicken meat compared with human clinical isolatesNkuchia M M'ikanatha, Carol H Sandt, A Russell Localio, et al.
Cancer|March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitorsAllison Ackerman, Oliver Klein, David F McDermott, et al.
Pageof 57